October 7 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that its sales revenue increased 2% year-on-year in the first nine months of 2019 on the back of increased sales on the international market.
Sopharma's domestic sales fell 9% year-on-year in january-September, while sales abroad rose 10%, the company said in a bourse filing.
In September alone, sales rose by 31%. Exports were 66% higher on the year, while domestic sales dropped by 5%.
The company did not disclose information about the volumes of its sales revenue.
As at 13:30 CET on Monday, Sopharma shares traded unchanged at 3.34 levs ($1.87/1.70 euro) on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)